

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 6.21911709 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.08019080 |
| 3 | glutamate secretion (GO:0014047) | 5.79057518 |
| 4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.73816867 |
| 5 | vocalization behavior (GO:0071625) | 5.71949692 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.59964066 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.51554213 |
| 8 | synaptic vesicle maturation (GO:0016188) | 5.49454090 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.38848258 |
| 10 | locomotory exploration behavior (GO:0035641) | 5.19032157 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.18695282 |
| 12 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.01514392 |
| 13 | neuronal action potential propagation (GO:0019227) | 5.00011802 |
| 14 | protein localization to synapse (GO:0035418) | 4.93413509 |
| 15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.89646048 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.82183905 |
| 17 | neurotransmitter secretion (GO:0007269) | 4.80702263 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 4.80283594 |
| 19 | neuron cell-cell adhesion (GO:0007158) | 4.76499965 |
| 20 | sodium ion export (GO:0071436) | 4.70431076 |
| 21 | neuronal ion channel clustering (GO:0045161) | 4.69264996 |
| 22 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.65721661 |
| 23 | neuron-neuron synaptic transmission (GO:0007270) | 4.47441651 |
| 24 | synaptic transmission, glutamatergic (GO:0035249) | 4.46704910 |
| 25 | glutamate receptor signaling pathway (GO:0007215) | 4.36975019 |
| 26 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.31957417 |
| 27 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.22506921 |
| 28 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.21960957 |
| 29 | exploration behavior (GO:0035640) | 4.21810699 |
| 30 | axon ensheathment in central nervous system (GO:0032291) | 4.13303944 |
| 31 | central nervous system myelination (GO:0022010) | 4.13303944 |
| 32 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.12336484 |
| 33 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.09628009 |
| 34 | long-term synaptic potentiation (GO:0060291) | 4.09380673 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.99189529 |
| 36 | potassium ion homeostasis (GO:0055075) | 3.93619531 |
| 37 | gamma-aminobutyric acid transport (GO:0015812) | 3.87728287 |
| 38 | presynaptic membrane assembly (GO:0097105) | 3.87232312 |
| 39 | positive regulation of synapse maturation (GO:0090129) | 3.86030215 |
| 40 | positive regulation of membrane potential (GO:0045838) | 3.85304754 |
| 41 | neurotransmitter transport (GO:0006836) | 3.85024465 |
| 42 | L-amino acid import (GO:0043092) | 3.82024048 |
| 43 | establishment of mitochondrion localization (GO:0051654) | 3.80394915 |
| 44 | regulation of postsynaptic membrane potential (GO:0060078) | 3.80064730 |
| 45 | regulation of synaptic plasticity (GO:0048167) | 3.78801350 |
| 46 | long-term memory (GO:0007616) | 3.77887721 |
| 47 | regulation of synapse structural plasticity (GO:0051823) | 3.75474357 |
| 48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.73718423 |
| 49 | presynaptic membrane organization (GO:0097090) | 3.69139906 |
| 50 | postsynaptic membrane organization (GO:0001941) | 3.68628807 |
| 51 | synaptic vesicle endocytosis (GO:0048488) | 3.65921098 |
| 52 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.65694993 |
| 53 | positive regulation of dendritic spine development (GO:0060999) | 3.65095055 |
| 54 | regulation of neurotransmitter secretion (GO:0046928) | 3.63807232 |
| 55 | response to histamine (GO:0034776) | 3.62547505 |
| 56 | proline transport (GO:0015824) | 3.62337442 |
| 57 | axonal fasciculation (GO:0007413) | 3.62310717 |
| 58 | positive regulation of neurotransmitter transport (GO:0051590) | 3.61182488 |
| 59 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.59076538 |
| 60 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.58758042 |
| 61 | regulation of neurotransmitter levels (GO:0001505) | 3.57706113 |
| 62 | amino acid import (GO:0043090) | 3.57033329 |
| 63 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.56982375 |
| 64 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.53093460 |
| 65 | neuromuscular process controlling posture (GO:0050884) | 3.48513901 |
| 66 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.48239387 |
| 67 | cellular potassium ion homeostasis (GO:0030007) | 3.45481402 |
| 68 | potassium ion import (GO:0010107) | 3.43793482 |
| 69 | cell migration in hindbrain (GO:0021535) | 3.41773578 |
| 70 | cerebellar granule cell differentiation (GO:0021707) | 3.40242971 |
| 71 | regulation of neurotransmitter transport (GO:0051588) | 3.39175216 |
| 72 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.36978163 |
| 73 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.35548374 |
| 74 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.35548374 |
| 75 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.35231588 |
| 76 | neuron recognition (GO:0008038) | 3.35195554 |
| 77 | cellular sodium ion homeostasis (GO:0006883) | 3.35042637 |
| 78 | activation of protein kinase A activity (GO:0034199) | 3.34714251 |
| 79 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.33874547 |
| 80 | adult walking behavior (GO:0007628) | 3.33707256 |
| 81 | neuromuscular process controlling balance (GO:0050885) | 3.33084586 |
| 82 | regulation of vesicle fusion (GO:0031338) | 3.31524586 |
| 83 | positive regulation of synaptic transmission (GO:0050806) | 3.30959689 |
| 84 | cell communication by electrical coupling (GO:0010644) | 3.30061586 |
| 85 | neuromuscular synaptic transmission (GO:0007274) | 3.29738697 |
| 86 | startle response (GO:0001964) | 3.29576412 |
| 87 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.28149488 |
| 88 | acidic amino acid transport (GO:0015800) | 3.26663091 |
| 89 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.25398424 |
| 90 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.25193749 |
| 91 | membrane depolarization (GO:0051899) | 3.24271106 |
| 92 | transmission of nerve impulse (GO:0019226) | 3.23378856 |
| 93 | behavioral defense response (GO:0002209) | 3.23087565 |
| 94 | behavioral fear response (GO:0001662) | 3.23087565 |
| 95 | behavioral response to cocaine (GO:0048148) | 3.22865494 |
| 96 | synaptic transmission (GO:0007268) | 3.22374405 |
| 97 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.21717312 |
| 98 | regulation of synaptic transmission (GO:0050804) | 3.20068353 |
| 99 | cell differentiation in hindbrain (GO:0021533) | 3.19908056 |
| 100 | regulation of glutamate secretion (GO:0014048) | 3.19014558 |
| 101 | layer formation in cerebral cortex (GO:0021819) | 3.18004131 |
| 102 | dendritic spine organization (GO:0097061) | 3.16853678 |
| 103 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.15296865 |
| 104 | long term synaptic depression (GO:0060292) | 3.14293543 |
| 105 | learning (GO:0007612) | 3.13847247 |
| 106 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.13248029 |
| 107 | neurofilament cytoskeleton organization (GO:0060052) | 3.12619639 |
| 108 | regulation of dendritic spine development (GO:0060998) | 3.12173055 |
| 109 | regulation of synapse maturation (GO:0090128) | 3.10124247 |
| 110 | membrane depolarization during action potential (GO:0086010) | 3.09189078 |
| 111 | membrane hyperpolarization (GO:0060081) | 3.08788190 |
| 112 | response to auditory stimulus (GO:0010996) | 3.08434261 |
| 113 | regulation of female receptivity (GO:0045924) | 3.08179202 |
| 114 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.07927294 |
| 115 | synapse assembly (GO:0007416) | 3.06887372 |
| 116 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.06335828 |
| 117 | dendritic spine morphogenesis (GO:0060997) | 3.06132480 |
| 118 | fear response (GO:0042596) | 3.05109162 |
| 119 | synaptic vesicle transport (GO:0048489) | 3.03422935 |
| 120 | establishment of synaptic vesicle localization (GO:0097480) | 3.03422935 |
| 121 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.03374027 |
| 122 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.01469687 |
| 123 | female mating behavior (GO:0060180) | 3.00319108 |
| 124 | * transferrin transport (GO:0033572) | 2.97561148 |
| 125 | mechanosensory behavior (GO:0007638) | 2.95673197 |
| 126 | detection of calcium ion (GO:0005513) | 2.94890757 |
| 127 | auditory behavior (GO:0031223) | 2.94603411 |
| 128 | negative regulation of dendrite development (GO:2000171) | 2.92208076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.01679998 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.30524475 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.27634904 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.16137662 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.09063351 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.87904919 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.71145624 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.67783478 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.67783478 |
| 10 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.64743132 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.64488396 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.55723800 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51679838 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.51410107 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.49521676 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.47522382 |
| 17 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.40895871 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.33899737 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30648105 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.28563066 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.23052124 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.20611283 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.18674996 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.15988004 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.12142103 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10574093 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.10032670 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.09464537 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.00110128 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.93113589 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.90691388 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.86823242 |
| 33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86449176 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.83362041 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.78515088 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.77195704 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.74707269 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.62984573 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.54757612 |
| 40 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.47929623 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47448861 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43276556 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.41881852 |
| 44 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41095818 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40247424 |
| 46 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.40000820 |
| 47 | AR_25329375_ChIP-Seq_VCAP_Human | 1.38639943 |
| 48 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.38596651 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37427195 |
| 50 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35842468 |
| 51 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32502765 |
| 52 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.31428515 |
| 53 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.31276984 |
| 54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30745100 |
| 55 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30678322 |
| 56 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.30634241 |
| 57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26828078 |
| 58 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25156119 |
| 59 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.25089851 |
| 60 | FUS_26573619_Chip-Seq_HEK293_Human | 1.24072104 |
| 61 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.23942000 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23400654 |
| 63 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23164440 |
| 64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.21784477 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21620655 |
| 66 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20790579 |
| 67 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.20749056 |
| 68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.20533800 |
| 69 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19744296 |
| 70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17172793 |
| 71 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16109591 |
| 72 | KDM2B_26808549_Chip-Seq_K562_Human | 1.14382538 |
| 73 | TCF4_23295773_ChIP-Seq_U87_Human | 1.13946754 |
| 74 | AR_19668381_ChIP-Seq_PC3_Human | 1.13721353 |
| 75 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11588727 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10122016 |
| 77 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.07870196 |
| 78 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07689579 |
| 79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06144326 |
| 80 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06015771 |
| 81 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05525504 |
| 82 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.05293215 |
| 83 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04610732 |
| 84 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02726454 |
| 85 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02625657 |
| 86 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.02186621 |
| 87 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02082248 |
| 88 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01620142 |
| 89 | JUN_21703547_ChIP-Seq_K562_Human | 1.01420344 |
| 90 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00963837 |
| 91 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00238607 |
| 92 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99163098 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98331372 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96747077 |
| 95 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95270867 |
| 96 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.92735334 |
| 97 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92460824 |
| 98 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.92174550 |
| 99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91767527 |
| 100 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.89032221 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88810234 |
| 102 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88586035 |
| 103 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.87938970 |
| 104 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86742668 |
| 105 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.86546172 |
| 106 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86201810 |
| 107 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86174118 |
| 108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85975461 |
| 109 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.85602331 |
| 110 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.84979135 |
| 111 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84979135 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82952050 |
| 113 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.82680073 |
| 114 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.82564360 |
| 115 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82461168 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82240893 |
| 117 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81558148 |
| 118 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77086022 |
| 119 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.74225092 |
| 120 | POU3F1_26484290_ChIP-Seq_ESCss_Mouse | 0.73328656 |
| 121 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.72733550 |
| 122 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.72644014 |
| 123 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.69702333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.33020466 |
| 2 | MP0003880_abnormal_central_pattern | 5.32114587 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.25024560 |
| 4 | MP0009745_abnormal_behavioral_response | 3.63827821 |
| 5 | MP0009046_muscle_twitch | 3.57320654 |
| 6 | MP0002064_seizures | 3.47713036 |
| 7 | MP0004270_analgesia | 3.44955145 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.42624500 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.24945034 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.98907152 |
| 11 | MP0002822_catalepsy | 2.86721792 |
| 12 | MP0002272_abnormal_nervous_system | 2.82209218 |
| 13 | MP0002736_abnormal_nociception_after | 2.81120238 |
| 14 | MP0001486_abnormal_startle_reflex | 2.58127632 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.55486288 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.55016985 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.36519379 |
| 18 | MP0001440_abnormal_grooming_behavior | 2.27089827 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.23366313 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.10104615 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 2.01264306 |
| 22 | MP0005646_abnormal_pituitary_gland | 2.00136988 |
| 23 | MP0003787_abnormal_imprinting | 1.97219409 |
| 24 | MP0001970_abnormal_pain_threshold | 1.95069276 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.91405213 |
| 26 | MP0008569_lethality_at_weaning | 1.89239497 |
| 27 | MP0003879_abnormal_hair_cell | 1.89216562 |
| 28 | MP0005386_behavior/neurological_phenoty | 1.74573756 |
| 29 | MP0004924_abnormal_behavior | 1.74573756 |
| 30 | MP0006276_abnormal_autonomic_nervous | 1.72470606 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.70820190 |
| 32 | MP0001984_abnormal_olfaction | 1.67929320 |
| 33 | MP0002184_abnormal_innervation | 1.66109395 |
| 34 | MP0004811_abnormal_neuron_physiology | 1.64164395 |
| 35 | MP0003122_maternal_imprinting | 1.62980997 |
| 36 | MP0003329_amyloid_beta_deposits | 1.59197859 |
| 37 | MP0001529_abnormal_vocalization | 1.54868823 |
| 38 | MP0004142_abnormal_muscle_tone | 1.53630482 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.48740041 |
| 40 | MP0000778_abnormal_nervous_system | 1.45637444 |
| 41 | MP0002066_abnormal_motor_capabilities/c | 1.42139524 |
| 42 | MP0001905_abnormal_dopamine_level | 1.41693689 |
| 43 | MP0000955_abnormal_spinal_cord | 1.35868319 |
| 44 | MP0004858_abnormal_nervous_system | 1.33426523 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.31907863 |
| 46 | MP0001502_abnormal_circadian_rhythm | 1.28685555 |
| 47 | MP0003633_abnormal_nervous_system | 1.27216750 |
| 48 | MP0002837_dystrophic_cardiac_calcinosis | 1.26024986 |
| 49 | MP0001188_hyperpigmentation | 1.22813389 |
| 50 | MP0001348_abnormal_lacrimal_gland | 1.18679555 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.17093504 |
| 52 | MP0002876_abnormal_thyroid_physiology | 1.16252508 |
| 53 | MP0000751_myopathy | 1.15969849 |
| 54 | MP0008872_abnormal_physiological_respon | 1.11239773 |
| 55 | MP0004885_abnormal_endolymph | 1.09601298 |
| 56 | MP0003631_nervous_system_phenotype | 1.09016130 |
| 57 | MP0000013_abnormal_adipose_tissue | 1.01376647 |
| 58 | MP0002152_abnormal_brain_morphology | 0.97351514 |
| 59 | MP0005551_abnormal_eye_electrophysiolog | 0.97279523 |
| 60 | MP0010386_abnormal_urinary_bladder | 0.96623043 |
| 61 | MP0008874_decreased_physiological_sensi | 0.94847155 |
| 62 | MP0002229_neurodegeneration | 0.94846087 |
| 63 | MP0002069_abnormal_eating/drinking_beha | 0.93845070 |
| 64 | MP0001963_abnormal_hearing_physiology | 0.89344861 |
| 65 | MP0001986_abnormal_taste_sensitivity | 0.89031059 |
| 66 | MP0005535_abnormal_body_temperature | 0.85620094 |
| 67 | MP0004145_abnormal_muscle_electrophysio | 0.85007663 |
| 68 | MP0004215_abnormal_myocardial_fiber | 0.83691971 |
| 69 | MP0004085_abnormal_heartbeat | 0.83224035 |
| 70 | MP0004484_altered_response_of | 0.82434895 |
| 71 | MP0004742_abnormal_vestibular_system | 0.81424700 |
| 72 | MP0008877_abnormal_DNA_methylation | 0.78344964 |
| 73 | MP0001664_abnormal_digestion | 0.76970994 |
| 74 | MP0005394_taste/olfaction_phenotype | 0.76155163 |
| 75 | MP0005499_abnormal_olfactory_system | 0.76155163 |
| 76 | MP0004147_increased_porphyrin_level | 0.74743826 |
| 77 | MP0001177_atelectasis | 0.72973266 |
| 78 | MP0003632_abnormal_nervous_system | 0.72362243 |
| 79 | MP0000604_amyloidosis | 0.69482243 |
| 80 | MP0003646_muscle_fatigue | 0.67365044 |
| 81 | MP0002752_abnormal_somatic_nervous | 0.67221782 |
| 82 | MP0003075_altered_response_to | 0.67147157 |
| 83 | MP0002102_abnormal_ear_morphology | 0.66718334 |
| 84 | MP0002653_abnormal_ependyma_morphology | 0.65837559 |
| 85 | MP0003183_abnormal_peptide_metabolism | 0.65611904 |
| 86 | MP0003634_abnormal_glial_cell | 0.64924975 |
| 87 | MP0000026_abnormal_inner_ear | 0.64377419 |
| 88 | MP0000631_abnormal_neuroendocrine_gland | 0.64286313 |
| 89 | MP0003861_abnormal_nervous_system | 0.63868215 |
| 90 | MP0004043_abnormal_pH_regulation | 0.62535687 |
| 91 | MP0001485_abnormal_pinna_reflex | 0.61279443 |
| 92 | MP0003137_abnormal_impulse_conducting | 0.60986322 |
| 93 | MP0003690_abnormal_glial_cell | 0.60917562 |
| 94 | MP0004233_abnormal_muscle_weight | 0.60761047 |
| 95 | MP0002090_abnormal_vision | 0.60421566 |
| 96 | MP0003938_abnormal_ear_development | 0.58252108 |
| 97 | MP0001299_abnormal_eye_distance/ | 0.57574120 |
| 98 | MP0005171_absent_coat_pigmentation | 0.57144170 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.56475261 |
| 100 | MP0005187_abnormal_penis_morphology | 0.56441503 |
| 101 | MP0001943_abnormal_respiration | 0.55164392 |
| 102 | MP0000920_abnormal_myelination | 0.54115754 |
| 103 | MP0005623_abnormal_meninges_morphology | 0.52712429 |
| 104 | MP0003121_genomic_imprinting | 0.52529116 |
| 105 | MP0010768_mortality/aging | 0.51689500 |
| 106 | MP0003123_paternal_imprinting | 0.51504792 |
| 107 | MP0010769_abnormal_survival | 0.50307809 |
| 108 | MP0002638_abnormal_pupillary_reflex | 0.50263861 |
| 109 | MP0002082_postnatal_lethality | 0.49926195 |
| 110 | MP0010770_preweaning_lethality | 0.49926195 |
| 111 | MP0003956_abnormal_body_size | 0.49472885 |
| 112 | MP0004130_abnormal_muscle_cell | 0.49440230 |
| 113 | MP0006035_abnormal_mitochondrial_morpho | 0.49161890 |
| 114 | MP0008961_abnormal_basal_metabolism | 0.48264744 |
| 115 | MP0000639_abnormal_adrenal_gland | 0.44707529 |
| 116 | MP0005253_abnormal_eye_physiology | 0.44205416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.97994569 |
| 2 | Myokymia (HP:0002411) | 6.66031119 |
| 3 | Atonic seizures (HP:0010819) | 6.02601112 |
| 4 | Focal seizures (HP:0007359) | 6.02153566 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.85659633 |
| 6 | Febrile seizures (HP:0002373) | 5.43536546 |
| 7 | Visual hallucinations (HP:0002367) | 5.15347549 |
| 8 | Absence seizures (HP:0002121) | 4.86638798 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.53176219 |
| 10 | Dialeptic seizures (HP:0011146) | 4.45059843 |
| 11 | Hyperventilation (HP:0002883) | 4.37316661 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.14738115 |
| 13 | Broad-based gait (HP:0002136) | 3.61702571 |
| 14 | Gaze-evoked nystagmus (HP:0000640) | 3.55696470 |
| 15 | Cerebral hypomyelination (HP:0006808) | 3.42040567 |
| 16 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.40698834 |
| 17 | Abnormality of the corticospinal tract (HP:0002492) | 3.40565924 |
| 18 | Action tremor (HP:0002345) | 3.33116887 |
| 19 | Abnormal eating behavior (HP:0100738) | 3.31643398 |
| 20 | Dysdiadochokinesis (HP:0002075) | 3.22802767 |
| 21 | Poor eye contact (HP:0000817) | 3.21789276 |
| 22 | Neurofibrillary tangles (HP:0002185) | 3.16191731 |
| 23 | Amblyopia (HP:0000646) | 3.10428406 |
| 24 | Depression (HP:0000716) | 3.08249774 |
| 25 | Papilledema (HP:0001085) | 3.06900565 |
| 26 | Anxiety (HP:0000739) | 3.06284517 |
| 27 | Truncal ataxia (HP:0002078) | 3.02680238 |
| 28 | Dysmetria (HP:0001310) | 2.97645064 |
| 29 | Abnormal social behavior (HP:0012433) | 2.95845979 |
| 30 | Impaired social interactions (HP:0000735) | 2.95845979 |
| 31 | Pheochromocytoma (HP:0002666) | 2.86356023 |
| 32 | Dysmetric saccades (HP:0000641) | 2.74791996 |
| 33 | Epileptiform EEG discharges (HP:0011182) | 2.74199604 |
| 34 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.74132051 |
| 35 | Abnormality of the lower motor neuron (HP:0002366) | 2.73641250 |
| 36 | Ankle clonus (HP:0011448) | 2.73616728 |
| 37 | Supranuclear gaze palsy (HP:0000605) | 2.72698622 |
| 38 | Scanning speech (HP:0002168) | 2.72074514 |
| 39 | Abnormal hair whorl (HP:0010721) | 2.71967455 |
| 40 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.69673725 |
| 41 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.69673725 |
| 42 | Progressive inability to walk (HP:0002505) | 2.69052951 |
| 43 | Polyphagia (HP:0002591) | 2.67776251 |
| 44 | Peripheral hypomyelination (HP:0007182) | 2.64422553 |
| 45 | Neuroendocrine neoplasm (HP:0100634) | 2.64398383 |
| 46 | Impaired smooth pursuit (HP:0007772) | 2.64140200 |
| 47 | Postural instability (HP:0002172) | 2.62492030 |
| 48 | Abnormality of binocular vision (HP:0011514) | 2.61609667 |
| 49 | Diplopia (HP:0000651) | 2.61609667 |
| 50 | Akinesia (HP:0002304) | 2.58539860 |
| 51 | Neuronal loss in central nervous system (HP:0002529) | 2.54630838 |
| 52 | Drooling (HP:0002307) | 2.51141038 |
| 53 | Excessive salivation (HP:0003781) | 2.51141038 |
| 54 | Status epilepticus (HP:0002133) | 2.50712326 |
| 55 | Genetic anticipation (HP:0003743) | 2.50072675 |
| 56 | EEG with generalized epileptiform discharges (HP:0011198) | 2.49316915 |
| 57 | Inability to walk (HP:0002540) | 2.46119119 |
| 58 | Bradykinesia (HP:0002067) | 2.45916751 |
| 59 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.41740731 |
| 60 | Tetraplegia (HP:0002445) | 2.40987469 |
| 61 | Impaired vibratory sensation (HP:0002495) | 2.38966522 |
| 62 | Clonus (HP:0002169) | 2.38170169 |
| 63 | Split foot (HP:0001839) | 2.35316557 |
| 64 | Hypsarrhythmia (HP:0002521) | 2.33001319 |
| 65 | Amyotrophic lateral sclerosis (HP:0007354) | 2.32827930 |
| 66 | Focal dystonia (HP:0004373) | 2.32803246 |
| 67 | Urinary urgency (HP:0000012) | 2.32731219 |
| 68 | Spastic tetraplegia (HP:0002510) | 2.32399151 |
| 69 | Gait imbalance (HP:0002141) | 2.32171644 |
| 70 | Agitation (HP:0000713) | 2.32152145 |
| 71 | Failure to thrive in infancy (HP:0001531) | 2.29830539 |
| 72 | Torticollis (HP:0000473) | 2.28695546 |
| 73 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.28438067 |
| 74 | CNS hypomyelination (HP:0003429) | 2.28018135 |
| 75 | Absent speech (HP:0001344) | 2.26312905 |
| 76 | Fetal akinesia sequence (HP:0001989) | 2.26208782 |
| 77 | Stereotypic behavior (HP:0000733) | 2.22175793 |
| 78 | Mutism (HP:0002300) | 2.21714825 |
| 79 | Resting tremor (HP:0002322) | 2.21350822 |
| 80 | Hemiparesis (HP:0001269) | 2.20791716 |
| 81 | Obstructive sleep apnea (HP:0002870) | 2.20474311 |
| 82 | Poor suck (HP:0002033) | 2.19911152 |
| 83 | Hemiplegia (HP:0002301) | 2.18817412 |
| 84 | Generalized myoclonic seizures (HP:0002123) | 2.18812188 |
| 85 | Spastic gait (HP:0002064) | 2.18641008 |
| 86 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.13454024 |
| 87 | Delusions (HP:0000746) | 2.10543700 |
| 88 | Congenital primary aphakia (HP:0007707) | 2.10040326 |
| 89 | Apathy (HP:0000741) | 2.09987522 |
| 90 | Termporal pattern (HP:0011008) | 2.08313158 |
| 91 | Insidious onset (HP:0003587) | 2.08313158 |
| 92 | Protruding tongue (HP:0010808) | 2.07753034 |
| 93 | Acute necrotizing encephalopathy (HP:0006965) | 2.07510670 |
| 94 | Incomplete penetrance (HP:0003829) | 2.06556557 |
| 95 | Specific learning disability (HP:0001328) | 2.06205620 |
| 96 | Blue irides (HP:0000635) | 2.06098302 |
| 97 | Limb dystonia (HP:0002451) | 2.02941065 |
| 98 | Medial flaring of the eyebrow (HP:0010747) | 2.01335128 |
| 99 | Gait ataxia (HP:0002066) | 2.00244590 |
| 100 | Annular pancreas (HP:0001734) | 2.00208321 |
| 101 | Craniofacial dystonia (HP:0012179) | 1.99168497 |
| 102 | Insomnia (HP:0100785) | 1.96139630 |
| 103 | Nephrogenic diabetes insipidus (HP:0009806) | 1.95895814 |
| 104 | Oligomenorrhea (HP:0000876) | 1.95467547 |
| 105 | Choreoathetosis (HP:0001266) | 1.95268834 |
| 106 | Ventricular fibrillation (HP:0001663) | 1.94522983 |
| 107 | Diminished motivation (HP:0000745) | 1.92328894 |
| 108 | Progressive macrocephaly (HP:0004481) | 1.91899551 |
| 109 | Psychosis (HP:0000709) | 1.91437295 |
| 110 | Hypoventilation (HP:0002791) | 1.91293359 |
| 111 | Spastic tetraparesis (HP:0001285) | 1.90546926 |
| 112 | Rapidly progressive (HP:0003678) | 1.89749858 |
| 113 | Hyperthyroidism (HP:0000836) | 1.88188603 |
| 114 | Narrow nasal bridge (HP:0000446) | 1.87111114 |
| 115 | Rigidity (HP:0002063) | 1.86845638 |
| 116 | Cholecystitis (HP:0001082) | 1.85534299 |
| 117 | Abnormal gallbladder physiology (HP:0012438) | 1.85534299 |
| 118 | Hypoplasia of the corpus callosum (HP:0002079) | 1.85015957 |
| 119 | Esotropia (HP:0000565) | 1.83519529 |
| 120 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.83353745 |
| 121 | Intention tremor (HP:0002080) | 1.83089693 |
| 122 | Abnormality of saccadic eye movements (HP:0000570) | 1.82267229 |
| 123 | Hand muscle atrophy (HP:0009130) | 1.81414976 |
| 124 | Sleep apnea (HP:0010535) | 1.80826533 |
| 125 | Cerebral inclusion bodies (HP:0100314) | 1.80599395 |
| 126 | Abnormality of the labia minora (HP:0012880) | 1.80285302 |
| 127 | Lower limb muscle weakness (HP:0007340) | 1.80190832 |
| 128 | Paraplegia (HP:0010550) | 1.72598916 |
| 129 | Anomalous pulmonary venous return (HP:0010772) | 1.69332263 |
| 130 | Prolonged QT interval (HP:0001657) | 1.67510899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.38531282 |
| 2 | EPHA4 | 4.08895728 |
| 3 | CASK | 3.73108258 |
| 4 | MAP3K12 | 3.42236234 |
| 5 | MAP3K4 | 3.26298066 |
| 6 | MAP3K9 | 3.24038159 |
| 7 | MAP2K7 | 3.05690686 |
| 8 | DAPK2 | 2.68174557 |
| 9 | CDK19 | 2.57672537 |
| 10 | MINK1 | 2.46607217 |
| 11 | DAPK1 | 2.22228062 |
| 12 | MAP2K4 | 2.14030995 |
| 13 | PLK2 | 2.08359216 |
| 14 | RIPK4 | 1.99378936 |
| 15 | PAK6 | 1.80036752 |
| 16 | PRPF4B | 1.77490710 |
| 17 | MARK1 | 1.74954092 |
| 18 | KSR2 | 1.67870248 |
| 19 | ARAF | 1.67391794 |
| 20 | NTRK2 | 1.66929056 |
| 21 | GRK5 | 1.62295931 |
| 22 | KSR1 | 1.48767690 |
| 23 | CAMKK1 | 1.48646487 |
| 24 | CDK5 | 1.39670956 |
| 25 | PRKCG | 1.37051128 |
| 26 | CCNB1 | 1.35297202 |
| 27 | OXSR1 | 1.35063971 |
| 28 | TNIK | 1.25965529 |
| 29 | PRKD3 | 1.23251236 |
| 30 | CAMKK2 | 1.22469701 |
| 31 | FES | 1.19421805 |
| 32 | PNCK | 1.17984577 |
| 33 | AKT3 | 1.17632195 |
| 34 | SIK3 | 1.13838196 |
| 35 | NME1 | 1.12422540 |
| 36 | NTRK1 | 1.10259770 |
| 37 | MAP3K13 | 1.09083099 |
| 38 | MAPK13 | 1.08806674 |
| 39 | STK38 | 1.08177866 |
| 40 | CAMK2A | 1.07171971 |
| 41 | PTK2B | 1.06628333 |
| 42 | SGK223 | 1.01396898 |
| 43 | SGK494 | 1.01396898 |
| 44 | DYRK2 | 0.96623077 |
| 45 | LIMK1 | 0.96139529 |
| 46 | SGK2 | 0.95149785 |
| 47 | BMPR2 | 0.94036446 |
| 48 | CDK18 | 0.91825669 |
| 49 | CAMK2B | 0.91234056 |
| 50 | SIK2 | 0.88937057 |
| 51 | TSSK6 | 0.87877739 |
| 52 | UHMK1 | 0.86802496 |
| 53 | CAMK1 | 0.86377351 |
| 54 | CDK15 | 0.85314659 |
| 55 | CDK14 | 0.83270157 |
| 56 | PDK4 | 0.82735279 |
| 57 | PDK3 | 0.82735279 |
| 58 | PKN1 | 0.81139040 |
| 59 | MAP3K2 | 0.79631808 |
| 60 | RAF1 | 0.77510182 |
| 61 | NEK1 | 0.75009791 |
| 62 | CDK11A | 0.73990605 |
| 63 | PRKCH | 0.71634314 |
| 64 | CSNK1G3 | 0.69655601 |
| 65 | TNK2 | 0.69640788 |
| 66 | MAP3K11 | 0.69338609 |
| 67 | SGK3 | 0.69258036 |
| 68 | BRAF | 0.69024476 |
| 69 | TRIM28 | 0.67245839 |
| 70 | STK11 | 0.65662063 |
| 71 | PINK1 | 0.64986162 |
| 72 | RIPK1 | 0.64948712 |
| 73 | CSNK1A1L | 0.63888800 |
| 74 | PDK1 | 0.63788477 |
| 75 | DAPK3 | 0.62903993 |
| 76 | TYRO3 | 0.62879493 |
| 77 | PRKCE | 0.62133675 |
| 78 | SGK1 | 0.62072273 |
| 79 | DYRK1A | 0.59345030 |
| 80 | PDPK1 | 0.57156599 |
| 81 | ALK | 0.54805610 |
| 82 | MAP3K1 | 0.54403204 |
| 83 | TESK1 | 0.53343209 |
| 84 | CAMK2G | 0.52216407 |
| 85 | MAPK10 | 0.50839079 |
| 86 | DYRK1B | 0.50602772 |
| 87 | PHKG1 | 0.50205534 |
| 88 | PHKG2 | 0.50205534 |
| 89 | STK16 | 0.49776591 |
| 90 | CAMK2D | 0.49538638 |
| 91 | TAOK1 | 0.48444166 |
| 92 | BCR | 0.47305854 |
| 93 | RET | 0.47029091 |
| 94 | PAK3 | 0.45999593 |
| 95 | FER | 0.45288314 |
| 96 | FGR | 0.44910825 |
| 97 | LMTK2 | 0.42404598 |
| 98 | ADRBK2 | 0.41441215 |
| 99 | BRSK1 | 0.41162979 |
| 100 | CSNK1G1 | 0.41117363 |
| 101 | RPS6KA3 | 0.41112858 |
| 102 | CAMK4 | 0.41013410 |
| 103 | PRKACA | 0.40592420 |
| 104 | LATS2 | 0.40401004 |
| 105 | MAP2K1 | 0.40194439 |
| 106 | PDK2 | 0.39078138 |
| 107 | FYN | 0.38126366 |
| 108 | CSNK1G2 | 0.37665585 |
| 109 | PRKCA | 0.37150424 |
| 110 | MARK2 | 0.36213544 |
| 111 | ROCK2 | 0.35960275 |
| 112 | ADRBK1 | 0.35643121 |
| 113 | CSNK1A1 | 0.35181851 |
| 114 | CSNK1E | 0.35011948 |
| 115 | MUSK | 0.33606412 |
| 116 | NEK6 | 0.33439071 |
| 117 | PRKCZ | 0.33356948 |
| 118 | GRK7 | 0.33314251 |
| 119 | MAP4K2 | 0.33310351 |
| 120 | MAPK12 | 0.32367056 |
| 121 | WNK3 | 0.32363701 |
| 122 | PRKG1 | 0.31088460 |
| 123 | WNK1 | 0.30657949 |
| 124 | FGFR2 | 0.30357933 |
| 125 | MAPK8 | 0.30214578 |
| 126 | CSNK1D | 0.26015355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.20431647 |
| 2 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.98537863 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.87876494 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.81510496 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.80053285 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.71203543 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.70660273 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.61830353 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.54432439 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.50202365 |
| 11 | * Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.40533368 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.14361868 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.13152353 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.02942582 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.97322470 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.93328443 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.81208264 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.72341945 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.71218865 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.68878386 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.67132014 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.66803503 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.63731529 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.56709625 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.47742304 |
| 26 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.47125330 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.46273024 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.42279200 |
| 29 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.31328113 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.26423350 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25577473 |
| 32 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.24387657 |
| 33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21186715 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.18874036 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.16579577 |
| 36 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16040510 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.15576331 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.15161165 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.13625661 |
| 40 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10147354 |
| 41 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.07955872 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07746546 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04636352 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.03383978 |
| 45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00272938 |
| 46 | Phototransduction_Homo sapiens_hsa04744 | 0.94733003 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 0.93951347 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93644912 |
| 49 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93567704 |
| 50 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92744737 |
| 51 | Glioma_Homo sapiens_hsa05214 | 0.89748245 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85836695 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85313294 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.85264009 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80069890 |
| 56 | Axon guidance_Homo sapiens_hsa04360 | 0.79706158 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77361729 |
| 58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74645115 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70029974 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69860980 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63425783 |
| 62 | Huntingtons disease_Homo sapiens_hsa05016 | 0.62256645 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60580381 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58460224 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57985094 |
| 66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57885009 |
| 67 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.57045679 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54915184 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53552741 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53217939 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50873906 |
| 72 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49857382 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.48196661 |
| 74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47181488 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46279521 |
| 76 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.45308485 |
| 77 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43756264 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43082034 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42733080 |
| 80 | Alcoholism_Homo sapiens_hsa05034 | 0.40991610 |
| 81 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.40848870 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40479118 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39410016 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38146674 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36643775 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35990968 |
| 87 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.34942506 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34941040 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32930139 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32437865 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.31951940 |
| 92 | * Phagosome_Homo sapiens_hsa04145 | 0.31639258 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.31349650 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29710742 |
| 95 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28623372 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.28461078 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28218829 |
| 98 | Bile secretion_Homo sapiens_hsa04976 | 0.26866327 |
| 99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26720684 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.25707224 |
| 101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.25337544 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24937046 |
| 103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.22595607 |
| 104 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.22047441 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21946783 |
| 106 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.21535755 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.21477185 |
| 108 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.21447277 |
| 109 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21214540 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.20914013 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.20233813 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.20076877 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.19960334 |
| 114 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.19864938 |
| 115 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.19144635 |

